News ResMed, Inc.

Equities

Real-time Estimate Cboe BZX Other stock markets 02:28:13 2024-04-26 pm EDT			5-day change	1st Jan Change
217.2 ^USD	+18.44%		+21.06%	+25.87%

08:13pm	Top Midday Gainers	MT
07:54pm	Sector Update: Health Care Stocks Higher in Afternoon Trading	MT

Top Midday Gainers	02:13pm	MT
Sector Update: Health Care Stocks Higher in Afternoon Trading	01:54pm	MT
In-Line Inflation Data, Tech Earnings Lift US Equity Indexes	01:35pm	MT
Sector Update: Health Care	01:33pm	MT
KeyBanc Adjusts Price Target on ResMed to $238 From $227	11:37am	MT
ResMed's Fiscal Q3 Non-GAAP Earnings, Revenue Increase; Shares Up Over 17%	11:04am	MT
Jefferies Adjusts Price Target on ResMed to $180 From $164	10:36am	MT
Oppenheimer Adjusts ResMed Price Target to $200 From $205, Maintains Outperform Rating	09:09am	MT
JPMorgan Adjusts Price Target on ResMed to $225 From $198	09:00am	MT
Mizuho Adjusts Price Target on ResMed to $220 From $215	08:09am	MT
Needham Adjusts Price Target on ResMed to $236 From $224	08:01am	MT
Morgan Stanley Adjusts Price Target on ResMed to $219 From $207	06:40am	MT
RBC Adjusts Price Target on ResMed to $200 From $187	06:18am	MT
ResMed Declares Quarterly Dividend as Fiscal Q3 Profit Jumps 29%; Shares Up 7%	11:21pm	MT
ResMed tops quarterly profit estimates on strong demand for sleep apnea devices	06:12pm	RE
ResMed : Q3 2024 ResMed Earnings Results Webcast Corporate 1-Pager	06:02pm	PU
ResMed : Q3 2024 ResMed Earnings Results Webcast Presentation	06:02pm	PU
ResMed Fiscal Q3 Non-GAAP Earnings, Revenue Increase; Shares Rise After Hours	Apr. 25	MT
Transcript : ResMed Inc., Q3 2024 Earnings Call, Apr 25, 2024	Apr. 25
ResMed: Fiscal Q3 Earnings Snapshot	Apr. 25	AQ

No results for this search

ResMed, Inc. continues to make headway in the sleep market

December 11, 2023 at 05:55 am EST